Cashu
Organogenesis Holdings: Pioneering Regenerative Medicine in Wound Care Solutions
about 7 hours ago
Stocks
Health Care
orgo
Organogenesis Holdings
NASDAQ: ORGO
+1.75 (+44.99%)
5.64
USD
At close at Nov 07, 21:10 UTC
Overview
Loading chart...
Key Stats
Market Cap
493.46M
Dividend Yield
0.00%
P/E Ratio
-31.66
EPS
-0.02
Revenue
482.04M
Avg. Volume
987.04K
About
What does ORGO do?
Organogenesis Holdings, a regenerative medical company based in Canton, Massachusetts, specializes in advanced wound care and surgical products, employing 862 staff since its IPO on December 2, 2016. Their portfolio includes Apligraf, Dermagraft, and various placental allografts for treating wounds and soft tissue repairs.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.